United States: The Future Of Medicare Physician Reimbursement: 10 Major Takeaways From The MACRA Proposed Rule

On April 27, 2016, just over a year after the Medicare Access and CHIP Reauthorization Act (MACRA) was signed into law, the Department of Health and Human Services (HHS) unveiled the long-awaited proposed rule to begin its implementation. The 962-page notice offers important insight for health care providers into how the Center for Medicare and Medicaid Services (CMS) will link physician payments to quality care through MACRA.

On April 16, 2015, President Obama signed MACRA into law, marking the end to the unpopular Sustainable Growth Rate (SGR) and transforming Medicare by moving away from traditional fee-for-service payments. MACRA will limits aggregate Medicare physician payments to a 0.5% increase per year through 2019, and will tie 4% of a physician's annual Medicare payments to one of two paths: (1) a Merit-Based Incentive Payment System (MIPS) for MIPS-eligible professionals, or (2) participation in Alternative Payment Models (APMs).

The expansive April 2016 proposed rule sets forth the details on how CMS proposes to establish these two paths and what will be required of health care providers under each.

10 MAJOR TAKEAWAYS

1.  The first performance period will occur in 2017.

Under MACRA, beginning in 2019, "MIPS-eligible clinicians" will receive a composite performance score of 0-100 based on an assessment under the four weighted performance standards, described below, which would be compared to a performance threshold. MIPS-eligible clinicians would then receive either positive, negative, or no adjustments based on their composite performance score. CMS proposes to begin measuring performance for doctors and other clinicians through MIPS in 2017, with payments based on those measures to begin in 2019. Similarly, 2017 will be the first performance year for Qualified Professionals (QPs) participating in APMs.

2.  Most covered professionals must report MIPS data in 2017 as such data will be used to determine which clinicians are QPs.

Most Medicare clinicians will submit data in the Quality Payment Program through MIPS in 2017. CMS will use that MIPS data to determine which clinicians meet the requirements for the APM track as QPs.

3.  CMS proposes a broader definition of who will qualify as a "MIPS-eligible clinician."

The proposed rule defines a "MIPS-eligible clinician" to be a Medicare Part B clinician, including physician, a physician assistant, a nurse practitioner, a clinical nurse specialist, a certified registered nurse anesthetist, and a group that includes such professionals." Medicare Part B clinicians may be exempted from the payment adjustment under MIPS if they are newly enrolled in Medicare, have less than or equal to $10,000 in Medicare charges and less than or equal to 100 Medicare patients, or are significantly participating in APMs.

CMS also distinguishes between "patient-facing" and "non-patient facing" encounters to give consideration to the circumstances of professional types who typically furnish services that do not involve face-to-face interaction with a patient. The proposed rule defines a "non-patient facing MIPS-eligible clinician" as an individual MIPS-eligible clinician or group that bills 25 or fewer patient-facing encounters during a performance period. "Patient-facing" encounters include general office visits, outpatient visits, and surgical procedural codes under the physician fee schedule. CMS also proposes to include telehealth services in the definition of patient-facing encounters. CMS intends to publish the proposed list of patient-facing encounter codes on its website.

4.  Aggregate payment adjustments under MIPS will increase over time.

The law requires MIPS to be budget neutral, therefore clinicians' MIPS scores will be used to compute a positive, negative, or neutral adjustment to their Medicare Part B payments. Both positive and negative adjustments will increase over time, as follows:

  • For 2019, 4%
  • For 2020, 5%
  • For 2021, 7%
  • For 2022 and after, 9%

5.  MIPS will pay physicians based on four weighted performance categories.

Under MACRA, MIPS combined the existing Electronic Health Record (EHR) and Meaningful Use Incentive Program, the Physician Reporting System (PQRS), and the Value-Based Modifier (VBM) in hopes of streamlining and reducing the reporting burden and to add flexibility in physician practices. MIPS will assess physicians' performance across four weighted categories, with respective percentage weights changing periodically. The proposed rule further defines these performance categories:

  • Quality (50% of total score in year 1): For most MIPS eligible clinicians, clinicians must report a minimum of six measures (versus the nine measures currently required under Physician Quality Reporting System) with at least one cross-cutting measure (for patient-facing MIPS eligible clinicians) and an outcome measure. If an outcome measure if not applicable, the clinician must instead report one other high priority measure, i.e., appropriate use, patient safety, efficiency, patient experience, or care coordination.
  • Advancing Care Information (25% of total score in year 1): Formerly recognized as "Meaningful Use," clinicians choose to report customizable measures that reflect how they use technology in their day-to-day practice, with a particular emphasis on interoperability and information exchange. The overall score will be made up of a base score and a performance score.
  • Clinical Practice Improvement Activities (15% of total score in year 1): Clinicians are afforded flexibility in selecting activities that match the goals of their practice. CMS proposes that clinicians participate in CPIAs for at least 90 days, with points assigned to over 90 activities. There is no required minimum number of activities to meet this requirement. Clinicians are rewarded for clinical practice improvements, such as activities focused on care coordination, beneficiary engagement, and patient safety.
  • Resource Use (10% of total score in year 1): MIPS will calculate scores based on Medicare claims, meaning there is no additional reporting requirement. CMS will continue two measures from the current Value-Based Payment Modifier: total cost per capita for all attributed beneficiaries and the Medicare Spending per Beneficiary measure, with adjustments. CMS proposes 40 episode-specific measures to account for differences among specialties.

6.  Physicians can expect greater public reporting and transparency.

CMS proposes a process for public reporting of MIPS information regarding the performance of MIPS-eligible clinicians or groups through Physician Compare. Beginning July 1, 2017, CMS also proposes to provide clinicians with performance feedback on the quality and resource use categories of MIPS. This is meant to ensure that MIPS results are useful and accurate. The rule also proposes to adopt a targeted review process under which a MIPS eligible clinician may request that CMS review the calculation of the adjustment factor and, as applicable, the calculation of additional MIPS adjustment factors applicable for a given year. There is no further judicial or administrative review available.

7.  Qualifying for the APM path will become increasingly challenging.

MACRA established that Medicare physicians who participate to a sufficient extent in various APMs could be exempt from the MIPS reporting requirements and qualify for financial bonuses. However, "qualifying participants" (QPs) must meet increasing thresholds for the percentage of their revenue that is received through qualifying APMs. Broadly speaking, APMs are payment models such as Accountable Care Organizations (ACOs) and patient-centered medical homes (PCMHs). The proposed rule defines an "Advanced APM" as those in which clinicians accept risk for providing coordinated, high-quality care. An Advanced APM must (1) require participants to use certified EHR technology, (2) provide payment for covered professional services based on quality measures comparable to those used in the quality performance category, and (3) be either a Medical Home Model expanded under section 1115A of the Social Security Act or bear more than a nominal amount of risk for monetary loses.

An Advanced APM would meet the financial risk requirement if CMS would withhold payment, reduce rates, or require the entity to make payments to CMS if its actual expenditures exceeded expected expenditures. The total amount of risk must be at least 4% of the APM spending target. CMS states that it will notify the public on its website of which APMs qualify as Advanced APMs prior to the annual performance period, starting no later than 2017.

8.  Starting in 2021, CMS will include the All-Payer Combination Option.

Starting in performance year 2021, clinicians can qualify for incentive payments based in part on participation in Advanced APMs developed by Medicare Advantage plans and non-Medicare payers, such as private insurers or state Medicaid programs. If clinicians do not meet the required percentage of payments provided or patients cared for through an Advanced APM through Medicare alone, then payments and patients under payers beside Medicare, called "Other Payer Advanced APMs" will also be able to count towards their participation status. Similar to an Advanced APM, an Other Payer Advanced APM must (1) require participants to use certified EHR technology, (2) provide payment based on quality measures comparable to those used in the quality performance category of MIPS, and (3) be either a Medicaid Medical Home that is comparable to Medical Home Models expanded under section 1115A of the Social Security Act or bear more than a nominal amount of risk for monetary loses.

9.  There is flexibility designed to make it easy for clinicians to move between the MIPS track and the Advanced APM track.

All eligible clinicians that participate in APMs are considered MIPS-eligible clinicians unless and until they are determined to be either QPs or Partial Qualifying APM Participants (Partial QPs) who elect not to report under MIPS. In QP performance period 2017, CMS defines Partial QPs to be an Advanced APM participant that has at least 20% but less than 25% of their Medicare Part B payments for covered professional services through an Advanced APM Entity, or at least 10%, but less than 20%, of their Medicare patients served through an Advanced APM Entity. If an eligible clinician does not meet either of those standards, the eligible clinician would be subject to MIPS and receive the corresponding payment adjustment.

Partial QPs will have the option to elect whether or not to report under MIPS, which determines whether or not they will be subject to MIPS adjustments. An eligible clinician who is a Partial QP for a year and reports on applicable measures and activities as required under the MIPS is considered to be a MIPS eligible clinician for the year. CMS proposes that an Advanced APM Entity can change its election about whether or not to report under MIPS for a year at any time during the QP performance period, but the election will become permanent at the close of the QP performance period.

CMS also strives to provide flexibility for MIPS-eligible clinicians and expects the number of clinicians who participate in APMs to grow as the program matures. For example, MIPS participants who participate in APMs would receive credit toward scores in the Clinical Practice Improvement Activities category, which provides clinicians the opportunity to experiment with participation in APMs.

10.  CMS provides budget estimates for MIPS and APM paths.

CMS estimates that MIPS would distribute payment adjustments to between 687,000 to 746,000 eligible clinicians in 2019 based on MIPS eligible clinicians' performance in the four performance categories. CMS hopes to achieve budget neutrality with equally distributed negative payment adjustments ($833 million) and positive payment adjustments ($833 million), with approximately $500 million distributed in exceptional performance payments.

For APMs, CMS estimates that between 30,658 and 90,000 eligible clinicians will become QPs through participation in Advanced APMs, with between $146 million and $429 million APM Incentive Payments estimated to be distributed in 2019.

CONCLUSION    

Value based payment for physicians in Medicare is no longer an elusive goal, and the actions in 2017 will determine 2019 payment. Any organization operating or managing physician services of any size need to decide how they will respond, and, in particular, if it is feasible to get to QP status. The cost burden of compliance, in the context of overall Medicare payment increases over the next four years that will be substantially less than the rate of inflation, may make it increasingly difficult for smaller practices to survive, and may increase the number of doctors who opt out of Medicare in some high end urban markets. Hard and important decisions need to be made soon.

HHS has already received a high level of interest from commentators in preparing the proposed rule. The current 60-day comment period, set to expire June 27, 2016, will provide more opportunity for constructive recommendations from affected stakeholders.

The Future of Medicare Physician Reimbursement: 10 Major Takeaways from the MACRA Proposed Rule

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
 
In association with
Related Video
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement

Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of www.mondaq.com

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.

Disclaimer

Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.

Registration

Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.

Cookies

A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.

Links

This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.

Mail-A-Friend

If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.

Security

This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at enquiries@mondaq.com.

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.